Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Nucleic Acids Symposium Series (2004)
|
September 9, 2008
Synthesis and antiviral evaluation of a seven-membered sugar ring nucleoside analog, 9-(5-deoxy-beta-D-allo-septanosyl)-adenine
Gwenaëlle Sizun, Jean-François Griffon, Ludovic Griffe, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 2, 2015
Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease
François-René Alexandre, Guillaume Brandt, Catherine Caillet, et al.
JCI Insight
|
April 23, 2026
Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitis
Yunguan Wang, David Adeleke, Xiangfei Xie, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 27, 2014
Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease
Christophe Parsy, François-René Alexandre, Guillaume Brandt, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 14, 2016
Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase
Claire Pierra Rouvière, Agnès Amador, Eric Badaroux, et al.
Antiviral Chemistry & Chemotherapy
|
October 3, 2007
2'-C-Methyl branched pyrimidine ribonucleoside analogues: potent inhibitors of RNA virus replication
Samira Benzaria, Dorothée Bardiot, Tony Bouisset, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 28, 2015
Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320
Christophe C Parsy, François-René Alexandre, Valérie Bidau, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 19, 2017
Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor
Jean-Laurent Paparin, Agnès Amador, Eric Badaroux, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Nucleic Acids Symposium Series (2004)
|
September 9, 2008
Synthesis and antiviral evaluation of a seven-membered sugar ring nucleoside analog, 9-(5-deoxy-beta-D-allo-septanosyl)-adenine
Gwenaëlle Sizun, Jean-François Griffon, Ludovic Griffe, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 2, 2015
Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease
François-René Alexandre, Guillaume Brandt, Catherine Caillet, et al.
JCI Insight
|
April 23, 2026
Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitis
Yunguan Wang, David Adeleke, Xiangfei Xie, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 27, 2014
Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease
Christophe Parsy, François-René Alexandre, Guillaume Brandt, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 14, 2016
Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase
Claire Pierra Rouvière, Agnès Amador, Eric Badaroux, et al.
Antiviral Chemistry & Chemotherapy
|
October 3, 2007
2'-C-Methyl branched pyrimidine ribonucleoside analogues: potent inhibitors of RNA virus replication
Samira Benzaria, Dorothée Bardiot, Tony Bouisset, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 28, 2015
Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320
Christophe C Parsy, François-René Alexandre, Valérie Bidau, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 19, 2017
Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor
Jean-Laurent Paparin, Agnès Amador, Eric Badaroux, et al.
Page
of 3